Abstract |
Diabetes is a consequence of a decrease on functional β-cell mass. We have recently demonstrated that epoxypukalide (Epoxy) is a natural compound with beneficial effects on primary cultures of rat islets. In this study, we extend our previous investigations to test the hypothesis that Epoxy protects β-cells and improves glucose metabolism in STZ-induced diabetic mice. We used 3-months old male mice that were treated with Epoxy at 200 μg/kg body weight. Glucose intolerance was induced by multiple intraperitoneal low-doses of streptozotocin (STZ) on 5 consecutive days. Glucose homeostasis was evaluated measuring plasma insulin levels and glucose tolerance. Histomorphometry was used to quantify the number of pancreatic β-cells per islet. β-cell proliferation was assessed by BrdU incorporation, and apoptosis by TUNEL staining. Epoxy treatment significantly improved glucose tolerance and plasma insulin levels. These metabolic changes were associated with increased β-cell numbers, as a result of a two-fold increase in β-cell proliferation and a 50% decrease in β-cell death. Our results demonstrate that Epoxy improves whole-body glucose homeostasis by preventing pancreatic β-cell death due to STZ-induced toxicity in STZ-treated mice.
|
Authors | Jose F López-Acosta, Pablo Villa-Pérez, Cristina M Fernández-Díaz, Daniel de Luis Román, Ana R Díaz-Marrero, Mercedes Cueto, Germán Perdomo, Irene Cózar-Castellano |
Journal | Islets
(Islets)
Vol. 7
Issue 2
Pg. e1078053
( 2015)
ISSN: 1938-2022 [Electronic] United States |
PMID | 26406478
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Hypoglycemic Agents
- Insulin
- Lactones
- 11,12-epoxypukalide
- Glucose
|
Topics |
- Animals
- Diabetes Mellitus, Experimental
(drug therapy)
- Glucose
(metabolism)
- Glucose Tolerance Test
- Hypoglycemic Agents
(pharmacology)
- Insulin
(blood)
- Insulin-Secreting Cells
(drug effects)
- Lactones
(pharmacology)
- Male
- Mice
|